What is your preferred approach for WHO type 1, EBER negative, locally advanced nasopharyngeal carcinoma?

In the setting of limited data with EBER negativity and worse prognosis, would you use cisplatin based chemoRT followed by cisplatin, 5-fluorouracil as per INT0099 or gemcitabine, cisplatin neoadjuvant chemotherapy followed by chemoRT?